Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
letter
. 1994 Jul;70(825):521–522. doi: 10.1136/pgmj.70.825.521

Sudden cardiac death and the potential role of beta adrenoceptor-blocking drugs.

O M Jolobe
PMCID: PMC2397663  PMID: 7937438

Full text

PDF
521

Images in this article

521Figure 1
on p.521

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Charlier R., Deltour G., Baudine A., Chaillet F. Pharmacology of amiodarone, and anti-anginal drug with a new biological profile. Arzneimittelforschung. 1968 Nov;18(11):1408–1417. [PubMed] [Google Scholar]
  2. Côté P., Bourassa M. G., Delaye J., Janin A., Froment R., David P. Effects of amiodarone on cardiac and coronary hemodynamics and on myocardial metabolism in patients with coronary artery disease. Circulation. 1979 Jun;59(6):1165–1172. doi: 10.1161/01.cir.59.6.1165. [DOI] [PubMed] [Google Scholar]
  3. Nademanee K., Singh B. N., Stevenson W. G., Weiss J. N. Amiodarone and post-MI patients. Circulation. 1993 Aug;88(2):764–774. doi: 10.1161/01.cir.88.2.764. [DOI] [PubMed] [Google Scholar]
  4. Navarro-López F., Cosin J., Marrugat J., Guindo J., Bayes de Luna A. Comparison of the effects of amiodarone versus metoprolol on the frequency of ventricular arrhythmias and on mortality after acute myocardial infarction. SSSD Investigators. Spanish Study on Sudden Death. Am J Cardiol. 1993 Dec 1;72(17):1243–1248. doi: 10.1016/0002-9149(93)90291-j. [DOI] [PubMed] [Google Scholar]
  5. Nyman I., Larsson H., Wallentin L. Prevention of serious cardiac events by low-dose aspirin in patients with silent myocardial ischaemia. The Research Group on Instability in Coronary Artery Disease in Southeast Sweden. Lancet. 1992 Aug 29;340(8818):497–501. doi: 10.1016/0140-6736(92)91706-e. [DOI] [PubMed] [Google Scholar]
  6. Pfeffer M. A., Braunwald E., Moyé L. A., Basta L., Brown E. J., Jr, Cuddy T. E., Davis B. R., Geltman E. M., Goldman S., Flaker G. C. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med. 1992 Sep 3;327(10):669–677. doi: 10.1056/NEJM199209033271001. [DOI] [PubMed] [Google Scholar]
  7. Rajman I., Kendall M. J. Sudden cardiac death and the potential role of beta-adrenoceptor-blocking drugs. Postgrad Med J. 1993 Dec;69(818):903–911. doi: 10.1136/pgmj.69.818.903. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Yusuf S., Pepine C. J., Garces C., Pouleur H., Salem D., Kostis J., Benedict C., Rousseau M., Bourassa M., Pitt B. Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions. Lancet. 1992 Nov 14;340(8829):1173–1178. doi: 10.1016/0140-6736(92)92889-n. [DOI] [PubMed] [Google Scholar]
  9. Zarembski D. G., Nolan P. E., Jr, Slack M. K., Caruso A. C. Empiric long-term amiodarone prophylaxis following myocardial infarction. A meta-analysis. Arch Intern Med. 1993 Dec 13;153(23):2661–2667. [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES